BUSINESS REGISTRATION NUMBER
BRN 74878160

Live

Australian Newcastle Medicine Great Health Co., Limited

澳大利亞紐西臣醫藥大健康有限公司

Registry Verified: 2023-02-21

Jurisdiction: Hong Kong, China

Australian Newcastle Medicine Great Health Co., Limited (澳大利亞紐西臣醫藥大健康有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 3235433, and Business Registration Number (BRN) is 74878160. Incorporated on 2023-02-21, the entity has maintained continuous statutory operations for 3 years and 8 months, currently holding an active legal status of Live. The registered office is situated at ROOM 10, 23/F, NEW TREND CENTRE, 704 PRINCE EDWARD ROAD EAST, SAN PO KONG, KOWLOON, HONG KONG. In terms of statutory filings, a total of 3 statutory filings (latest filed on 2023-02-21) are indexed in the registry.

I. Corporate Profile & Statutory Registry Records

Official Chinese Name	澳大利亞紐西臣醫藥大健康有限公司	Official English Name	Australian Newcastle Medicine Great Health Co., Limited
Company Reg No. (CRN)	3235433	Business Reg No. (BRN / UBI)	74878160 HK Unique Business ID · US IRS Form W-8BEN-E Foreign TIN
Incorporation Date	2023-02-21	Company Category	Private company limited by shares
Current Legal Status	Live	Statutory Filing Cycle	2026-02-21(Current Cycle Pending Check)

Registered Office Address	ROOM 10, 23/F, NEW TREND CENTRE, 704 PRINCE EDWARD ROAD EAST, SAN PO KONG, KOWLOON, HONG KONGNew Trend Centre · Prince Edward · 4,981 Co-Located Entities →
Significant Controllers (SCR)	Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

#	Filing Date	Document No.	Document Name	Pages	Tariff
1	2023-02-21	70002978028	NNC1 Incorporation Form (Company Limited by Shares)Founding Shareholders & Directors	7	HK$ 28
2	2023-02-21	70002978030	A&A Articles of Association (A&A)	17	HK$ 33
3	2023-02-21	40020040703	CI Certificate of Incorporation (CI)	1	HK$ 20

III. Commercial Due Diligence & Regulatory Risk Screening

Cross-screened across 32 HK statutory regulators, court dockets & sanctions registers: 0 licences, 0 public litigation/HCCW records, 0 sanctions hits.